Scott Wilson

Scott Wilson, PhD, is an Assistant Professor in the Department of Biomedical Engineering at Johns Hopkins University, affiliated with the Translational Tissue Engineering Center. His research focuses on synthesizing immunomodulatory biomaterials to control adaptive immune responses for treating malignancies, infectious diseases, and autoimmune conditions. Key interests include tolerance-inducing therapies, spatial-temporal drug delivery, and nanoparticle formulations.

Education:

• PhD in Chemical Engineering (Bioengineering) from Georgia Institute of Technology (2011)
• MS in Chemical Engineering from University of Oklahoma (2004)
• BS in Chemical Engineering from University of Oklahoma (2001)

Research Interests: Wilson’s lab develops bespoke biomaterials to bias immune responses toward immunity or tolerance. Projects include cancer immunotherapy via polymeric glyco-adjuvants, allergy suppression through glycoengineered antigens, and antimicrobial coatings for titanium implants. His work bridges organic chemistry and biomedical applications, emphasizing preclinical validation.

Collaborative Grants: Wilson contributed to two Johns Hopkins Discovery Awards (2020 and 2024), fostering interdisciplinary projects. His lab collaborates on translational efforts, including gene therapy delivery systems and osseointegration enhancements.

Labs & Teams: The Wilson Laboratory for Biomaterials Synthesis and Immunoengineering focuses on engineering immune responses via functional biomaterials. Key themes include antigen-specific tolerance induction and targeted drug delivery platforms.